课题基金 / 基金详情

SOLID TUMOR SELECTIVE COMPOUNDS

SOLID TUMOR SELECTIVE COMPOUNDS
实体肿瘤选择性化合物
批准号:
2560975
负责人:
PAUL A GRIECO
金额:
$13.41万
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-06-01 至 2002-01-31

项目摘要

项目成果

PAUL A GRIECO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal focuses on the synthesis and biological evaluation of natural and unnatural quassinoids which display solid tumor selectivity. The major thrust of our program is the synthesis of quassinoid analogs for in vitro and in vivo studies in order to define the best candidate to move forward into the clinic. In addition this proposal concentrates on the total synthesis of scytophycin C and tolytoxin. The scytophycins and tolytoxins are solid tumor selective in vitro, however, despite being high priority candidates for in vivo evaluation, no material is available. A major effort will be devoted to probing the structural requirements for solid tumor activity. In part III of this grant application we propose to examine a number of Castela species (plants known to contain quassinoids) in hopes of finding a rich source of glaucarubolone and related quassinoids for our analog program and, more importantly, identifying novel cytotoxic quassinoids as well other natural products which will be solid tumor selective.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NEW PROTEOMIC REAGENT SYNTHESIS
NEW PROTEOMIC REAGENT SYNTHESIS
NEW PROTEOMIC REAGENT SYNTHESIS
400 MHZ NMR INSTRUMENT
  • 批准号:
    3519868
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    1988
  • 负责人:
    PAUL A GRIECO
  • 依托单位:
海外基金